BioXcel Therapeutics (BTAI) Competitor Comparison
We are evaluating the key criteria listed to compare BioXcel Therapeutics (BTAI) against its competitors in the Biotechnology industry.
Market Capitalization
264 / 368Gross Profits
137 / 278Total Revenue
233 / 300EBITDA
283 / 337Free Cashflow
282 / 352Quick Ratio
278 / 357Earnings per Share
293 / 359Dividend yield
0 / 6Total Cash
222 / 358Performance 3 years
349 / 368Performance 5 years
302 / 368Performance 10 years
268 / 368Linearity 3 years
196 / 366Linearity 5 years
75 / 368Linearity 10 years
80 / 368Total Rank
272 / 368Dividend Rank
68 / 368Valuation Rank
266 / 368Piotroski Rank
190 / 368Muliplier Rank
72 / 368Free Cashflow - BTAI ranking 282 / 352
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.